Osteosarcopenia (OS), a recently recognized syndrome characterized by the simultaneous occurrence of osteopenia/osteoporosis and sarcopenia, has emerged as an important concept in clinical practice. This integrated framework provides a comprehensive view of the musculoskeletal system, addressing a previously underappreciated aspect of muscle health. OS notably increases the risk of falls, fractures, hospitalization, and mortality in elderly patients with chronic diseases. Despite its growing clinical relevance, OS remains underdiagnosed, and its classification as a distinct syndrome is not universally accepted. The persistently high global prevalence of chronic diseases, along with their substantial medical, economic, and social burdens, underscores the urgent need for updated prevention and management strategies. This review advocates for greater awareness and improved management of OS in patients with chronic diseases. It examines the relationship between OS and chronic conditions, emphasizing its epidemiology, adverse outcomes, diagnostic approaches, pathophysiology, and potential management strategies.
基金:
National Natural Science Foundation of China [82460428]; Yunnan Provincial Department of Science and Technology- Kunming Medical University Joint Special Fund for Basic Research General Program [202501AY070001-166]; China Postdoctoral Science Foundation General Funding-Regional Special Support Program [2024MD763983]; Yunnan Health Training Project of High Level talents [H-2024026]; Youth Project of Yunnan Basic Research Programme of Yunnan Provincial Department of Science and Technology [202401AU070046]; Teachers' Project of Scientific Research Fund of Yunnan Provincial Department of Education - Special Project on Basic Research for Young Talents [2024J0180]; The fifth batch of 535 young academic backbone training subjects of the First Affiliated Hospital of Kunming Medical University [2025535Q08]; The 2024 Yunnan Province Colorful Cloud Postdoctoral Program Innovation Project, Education and Teaching Research Project of the First Affiliated Hospital of Kunming Medical University [2024 JY-17]; Golden Flower Enterprise Co., Ltd. Horizontal Project
第一作者机构:[1]Kunming Med Univ, Affiliated Hosp 1, Dept Orthoped, Kunming, Yunnan, Peoples R China
通讯作者:
推荐引用方式(GB/T 7714):
Yi Yong-Tao,Zhao Hao-Fan,Wang Wei-Zhou,et al.Osteosarcopenia: epidemiology, molecular mechanisms, and management[J].FRONTIERS IN ENDOCRINOLOGY.2025,16:doi:10.3389/fendo.2025.1577758.
APA:
Yi, Yong-Tao,Zhao, Hao-Fan,Wang, Wei-Zhou&Li, Xi.(2025).Osteosarcopenia: epidemiology, molecular mechanisms, and management.FRONTIERS IN ENDOCRINOLOGY,16,
MLA:
Yi, Yong-Tao,et al."Osteosarcopenia: epidemiology, molecular mechanisms, and management".FRONTIERS IN ENDOCRINOLOGY 16.(2025)